CASP3 and non-small cell lung carcinoma: For example, the lncRNA TATDN1 could contribute to DDP resistance in NSCLC by inhibiting apoptosis via a decreased cleaved caspase-3 level and increased Bcl-2 expression through the miR-451/TRIM66 axis [58].